Tell Congress to promote a strong FDA chief

[Guest guest]

You have 25 Consumer Power Points! Earn more. What are they? Learn!

 

 

 

Dear Mary,

 

Vioxx may may have contributed to thousands of deaths. The entire class of pain

relieving drugs known as COX-2 inhibitors--which includes Bextra and Celebrex

currently on the market--is now under tough scrutiny. And it seems like each day

there’s a new story about prescription drug safety problems.

 

That is why it is critical that the Food and Drug Administration, which has been

without a permanent director for much of the past four years, get a strong,

independent leader—one who will support solutions like a vigorous and

independent office of drug safety and the public release of information about

all clinical trials.

 

Yesterday the President moved to appoint Lester M. Crawford, a man who has

served as acting commissioner for the past several months. Tell your Senator to

“vet the vet” by demanding answers to tough questions about the FDA’s recent

track record on transparency and drug safety.

 

We need an FDA head who is independent of the drug industry and will take

decisive action to turn the agency around.

 

And there's one more thing you can do. After you take action yourself, please

forward this email to your friends and people you know who care about

prescription drug safety. Congress needs to know that this appointment is

critical for all of us.

 

Thanks again for all your help.

 

 

Sincerely,

Rob Schneider

PrescriptionforChange.org

A project of Consumers Union

101 Truman Ave.

Yonkers, NY 10703-1057

 

 

Donate |

 

Your Privacy |

 

Change Email Preferences |

 

About Consumers Union

 

 

 

 

http://www.blueaction.org

" Better to have one freedom too many than to have one freedom too few. "

http://www.sharedvoice.org/unamerican/